Experimental cancer drug JSI-1187 tested in early trial
Disease control
Terminated
This early-stage trial is testing an experimental drug called JSI-1187, alone or with another cancer drug (dabrafenib), in people with advanced solid tumors that have certain genetic changes. The main goal is to check safety and side effects. About 71 adults with tumors that have…
Phase: PHASE1 • Sponsor: JS InnoPharm, LLC • Aim: Disease control
Last updated Jun 26, 2026 12:40 UTC